Clinical Trial Update: Open-Label, Randomised Parallel-Group Study [Phase 3]

View source ↗

Summary

A Phase 3 open-label randomized study for prostate cancer sponsored by Ferring Pharmaceuticals was withdrawn from the trial registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: WITHDRAWN